BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-157

  1. 377 Posts.
    lightbulb Created with Sketch. 100
    Still some ways to go before retirement but if SB reaches 5% market share definitely would be life changing.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.